|Bid||440.00 x 0|
|Ask||442.00 x 0|
|Day's range||442.00 - 442.00|
|52-week range||370.00 - 511.40|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
OLDWICK, N.J., November 07, 2023--AM Best has assigned indicative Long-Term Issue Credit Ratings of "bbb" (Good) to subordinated issues, "bbb-" (Good) to preferred stock issues and "bbb+" (Good) to senior unsecured issues on the recently filed shelf registrations of Elevance Health, Inc. (Elevance Health) (Indianapolis, IN) [NYSE: ELV]. The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings of the previous shelf registration, which expir
INDIANAPOLIS, November 01, 2023--Elevance Health provides $1.42 million in grants for medical schools to implement IDD curriculum. Proposals for funding are currently being accepted.
INDIANAPOLIS, October 18, 2023--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2023 results reflecting strong financial performance across the enterprise.